Physician profile
Joseph Michael Gentile
NPI 1871757724
$49,952.70
in general payments reported to CMS, 2019-2025
16 companies · $5,987 in 2025
The $5,987 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,911 · 2020: $371 · 2021: $5,726 · 2022: $18K · 2023: $6,589 · 2024: $8,592 · 2025: $5,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $3,952 · Food and Beverage: $3,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,408.75 |
| Travel and Lodging | $3,952.06 |
| Food and Beverage | $3,806.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $35,571.99 | 2019-2025 | Catalyst Csr Shoulder System, Catalyst Total Csr, R1 Reverse Total Shoulder |
| Smith+Nephew, INC. | $5,395.72 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix, Microraptor |
| Encore Medical, Lp | $2,234.32 | 2019 | |
| Fx Shoulder Solutions, INC | $1,254.78 | 2019 | |
| Arthrex, INC. | $1,069.96 | 2023 | |
| Zimmer Biomet Holdings, INC. | $1,043.37 | 2020-2025 | Comprehensive Shoulder System |
| Peerless Surgical INC. | $992.33 | 2023-2025 | |
| Exactech, INC. | $934.97 | 2019-2024 | |
| Stryker Corporation | $659.66 | 2019-2024 | Aequalis Perform, Mako, Blueprint Patient Specific Instrumentation |
| Medacta USA, INC. | $418.60 | 2019-2024 | Reverse Shoulder |
| Wright Medical Technology, INC. | $163.34 | 2019 | |
| G21 Srl | $113.40 | 2024 | |
| Ferring Pharmaceuticals INC. | $38.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $35.29 | 2019 | |
| Bioventus LLC | $15.73 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,369,026.46 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gentile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.